BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
BECTON DICKINSON & CO
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$190.74−1.01 (-0.53%)
Close on Oct 19, 2026
- Market cap
- $52.48B
- P/E (TTM)
- 57.6
- Dividend yield
- 2.18%
BECTON DICKINSON & CO balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 46.9%
- Operating margin
- 10.7%
- Net margin
- 4.0%
- Return on equity, FY2025
- 6.5%
Financial strength
- Current ratio
- 0.87
- Debt to equity
- 0.69
- Debt to assets
- 33.1%
- Cash to current liabilities
- 7.5%
Valuation
- P/E ratio
- 57.6
- Price to sales
- 2.26
- Price to book
- 2.15
- Dividend yield
- 2.18%